RecommendationOffer men considering any treatment for LUTS an assessment of their baseline symptoms with a validated symptom score (for example, the IPSS) to allow assessment of subsequent symptom change.
Relative values of different outcomesResponse to treatment and improvement in symptoms were considered the most important outcomes.
Trade off between clinical benefits and harmsThe consensus of the GDG was that it was not essential for all men with LUTS to complete a symptom score. They felt that this was time consuming and did not add much to the medical history taking at initial assessment. The test was considered beneficial at the stage when men were considering treatment. This would then provide a baseline score to monitor their response to treatment.
Economic considerationsThe assessment of the baseline symptoms does not need expensive equipment or considerable staff time.
Quality of evidenceNo clinical or economic evidence was found.
Other considerationsThe GDG considered the difficulties in completing the symptom score for men who are blind, have learning disabilities or when English is not their first language. There is a Braille version of the IPSS which could be used and a translator could be provided for men if required.

From: 4, Diagnosis

Cover of The Management of Lower Urinary Tract Symptoms in Men
The Management of Lower Urinary Tract Symptoms in Men [Internet].
NICE Clinical Guidelines, No. 97.
National Clinical Guideline Centre (UK).
Copyright © 2010, National Clinical Guideline Centre.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of the National Clinical Guideline Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.